Abstract OBJECTIVES: To identify differentially expressed proteins from the aortic tissue of thoracic aortic dissection (TAD) with hypertension and normal aorta and to explore the potential molecular pathogenesis of TAD.
INTRODUCTION
Thoracic aortic dissection (TAD) is a catastrophic vascular disease in which blood flows through the aortic wall via an intimal tear, forcing the layers apart. The dissection extends anterograde or retrograde from the site of the intimal tear. This process weakens the aortic wall and can quickly lead to death, even with optimal treatment. Local pressure may play a role in the formation of aortic dissection. The molecular pathological processes occurring in the aortic wall as TAD develops are still unclear.
Many protein-focused studies have been performed to understand the pathogenesis of aortic aneurysm. The transforming growth factor-β (TGF-β) signalling pathway and protease pathways involving many proteins seem to directly contribute to aneurysm formation [1, 2] . It is uncertain whether the above-mentioned mechanisms or others take part in the pathogenesis of TAD.
Proteomics research, an experimental approach that is widely used in life sciences, has facilitated the analysis of the molecular mechanisms of diseases at protein level. Conventional comparative tissue proteomics using two-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS) has been applied to studies of aortic aneurysm and dissection [3, 4] . Our study used isobaric tags for relative and absolute quantitation (iTRAQ) technology, which is a more effective proteomics method to detect differentially expressed proteins. We examined aortic tissue from age-and gender-matched patients with and without TAD to explore the molecular mechanisms of this condition.
MATERIALS AND METHODS

Tissue source
Aorta tissue was obtained from 13 TAD patients with hypertension undergoing aortic replacement in the intimal tear position. Ascending aorta tissue samples of 13 age-and gender-matched patients with hypertension undergoing CABG without aortic dilatation served as a control group. Our investigation conforms to the principles outlined in the Declaration of Helsinki. Written informed consent was obtained from all patients, with the approval of the local ethics committee of Beijing Anzhen Hospital. Aortic tissue with adventitia removal was immediately snap-frozen in liquid nitrogen and stored at −70°C until protein analysis.
iTRAQ analysis (i) Samples preconditioning and protein quantification: the tissue samples were preconditioned and the eluent of each protein sample was quantitated using the Bradford method (Bio-Rad, Hercules, CA, USA). (ii) Protein denaturation and reduction: 20 µl of dissolution buffer, 1 μl of denaturant from a commercially available kit and 2 μl of reducing reagent were added to each tube, which already contained 100 μg of sample, before incubation at 60°C for 1 h. (iii) Alkylation and digestion: 1 μl of cysteine blocking reagent and 10 μl of trypsin solution were added successively to each tube. The tubes were then incubated at 37°C overnight. (iv) iTRAQ labelling: the peptide mixtures were labelled using the 4-plex iTRAQ labelling kit according to the iTRAQ™ Reagent Protocol. iTRAQ reagents 114 and 115 were used to label the peptides from the control group and the TAD group, respectively. After incubating the tubes at room temperature for 1 h, all iTRAQ-labelled tryptic peptide mixtures were combined for further purification and fractionation. (v) Liquid chromatography and tandem mass spectrum: the samples were fractionated by two-dimensional liquid-phase chromatography fractionation using the Eksigent nanoLCUltra™ 2D System. Data acquisition was performed with a TripleTOF 5600 System (AB SCIEX, Concord, USA) fitted with a Nanospray III source (AB SCIEX). (vi) Database search: data were processed using the Protein Pilot Software 4.0 (AB SCIEX, Foster City, USA) utilizing the Paragon and Progroup Algorithm. In this algorithm, all modifications listed in UniMod are searched simultaneously (http://www. unimod.org/) The tolerance was set at ±0.05 Da for peptides and ±0.05 Da for MS/MS fragments. The false discovery rate (FDR) analysis was also completed using the integrated tools in ProteinPilot. We adopted the fold change method of analysing the differentially expressed proteins described in a study by Glen et al. [5] , and a fold change cut-off ratio of >1.50 or <0.66 was selected to designate differentially expressed proteins (P < 0.05).
Western blotting
Relative abundance of differentially expressed proteins was examined using western blotting analysis. The standard procedure was performed with a mouse anti-decorin monoclonal antibody (Abcam plc, Cambridge, UK), a mouse anti-fibrillin-1 monoclonal antibody (Abcam plc), a mouse anti-emilin-1 monoclonal antibody (Abcam plc), a mouse anti-PARK7/DJ-1 monoclonal antibody (Abcam plc) and a mouse anti-histone H4 monoclonal antibody (Abcam plc).
Metacore analysis
Additionally, we performed pathway analysis using the Metacore software with the enrichment ontology of GeneGo Process
Networks to identify biological processes involving the proteins identified by iTRAQ. Metacore (GeneGo) uses a hypergeometric model to determine the significance of enrichment (Falcon and Gentleman). All reported pathways and biological processes are listed according to their GO enrichment score, as provided by the software packages as −log (P-value), and all have a FDR of less than 0.05%.
Statistical analysis
For statistical comparisons, the χ 2 test (n < 40, Fisher's exact test) and the parametric test (independent samples t-test, equal variances not assumed) were used. Fisher's exact χ 2 test was used for categorical data. Distributional normality and homogeneity of variance were tested for numerical data. Values were given as mean ± SD.
RESULTS
Patient characteristics
There were no significant differences in sex (TAD, 6 females and 7 males; coronary artery disease (CAD), 4 females and 9 males), χ 2 test, Fisher's exact test, P = 0.69) or the mean age (TAD, 63.17 ± 6.69; CAD, 64.31 ± 6.43; P = 0.53). Arterial hypertension was present in all patients. There were 5 patients with diabetes in the CAD group. All patients in the TAD group were diagnosed with acute type A aortic dissection. No patients with bicuspid aortic valve, Marfan syndrome or other connective tissue disorders were involved in our study. The aortic diameters at the site of sampling were 2.5 ± 0.3 cm in the CAD group and 5.1 ± 0.6 cm in the TAD group.
Differentially expressed proteins in thoracic aortic dissection
To identify newly expressed proteins in TAD that may help elucidate the development of this condition, the protein expressions of aortic tissue from 13 randomly selected TAD patients and 13 ageand gender-matched controls were compared using proteomics analysis. We identified 750 proteins from 6128 distinct peptides using the iTRAQ technology. A total of 36 proteins were significantly differentially expressed more than 1.5 times (>1.5 or <0.66) between TAD patients and the control group. Nineteen of these proteins were significantly down-regulated, and 17 were upregulated in patients with TAD. Table 1 lists the identified proteins.
Metacore enrichment analysis
Metacore enrichment analysis showed that the identified proteins were involved in a number of biological processes including cellmatrix adhesion interactions (COL1A1, Tenascin-C, LAMA5, Fibrillin, EMILIN-1, COL6A1, LAMG1, Fibrillin-1, Decorin; P = 2.994 × 10 biological processes. Experimental data from all files are shown for these networks, in which objects with cycle markers represent differentially expressed proteins from our results. Red cycle markers indicate up-regulated proteins, and blue cycle markers indicate down-regulated proteins. Figure 4 explains the various symbols in the network map.
Western blotting verification of the expression of five identified proteins
Confirmation of some proteins' differential expression was performed by western blot analysis. Among the 36 proteins that were of focus in this study, the expression levels of five selected proteins were examined (Fig. 5) .
Indication of TGF-β signalling activation in thoracic aortic dissection
TGF-β superfamily members regulate various cellular processes. Genetic studies have demonstrated an association between gene mutations in components of TGF-β signalling and aortic aneurysms [1] . However, the role of TGF-β signalling in the pathogenesis of TAD remains to be confirmed. Three important proteins that interact with TGF-β signalling, Fibrillin-1 (−2.655, P = 0.000), Emilin-1 (−2.333, P = 0.008) and Decorin (−6.486, P = 0.000) were expressed differentially and may participate in TAD formation directly through the TGF-β signalling pathway, thereby leading to ECM remodelling.
DISCUSSION
Thoracic aortic aneurysms (TAAs) develop as a result of maladaptive remodelling of the vascular ECM [1] . The remodelling is regulated through ontological pathways, mechanical stress or biochemical signalling (TGF-β1, matrix metalloproteinases, inflammation and oxidative stress) [6] . The relationship between aortic aneurysm and dissection has caused substantial confusion. In most cases, acute dissection develops in the absence of a preexisting aneurysm [7] . Local blood pressure may contribute to the formation of TAD, but the potential molecular mechanisms remain to be defined. Cystic media necrosis is a hallmark histological finding of aortic dissection [7] . Deficiencies of fibulin-5 have been noted in the aortas of patients with dissection in whom inherited connective tissue disease has been excluded, suggesting the general importance of deficiency in microfibrillar components in the stimulation of extracellular remodelling [8] . Substantial genetic advances have been made in the understanding of some inherited diseases including Marfan's and Ehlers-Danlos syndrome, which has implications for the understanding of aortic dissection in general [9] . However, there also seems to be a genetic basis for aortic dissection that is not associated with a recognized connective tissue deficiency syndrome [10, 11] . Proteomics is the large-scale study of proteins, particularly their structures and functions. Cardiovascular proteomics is a rapidly growing field, especially with the emergence of high-throughput MS-based techniques [12] . After the identification of proteins in a given sample, researchers are keen to determine how much of the protein is present, especially in a disease or a given state. In contrast to conventional gel-based proteomics quantification techniques, MS-based methods have evolved as the best techniques for In the aortic disease proteomics field, few studies have focused on TAD, and few studies use the iTRAQ technique; most studies have explored aortic aneurysm using traditional two dimension difference gel electrophoresis (2D-DIGE) methods. Gu et al. [13] identified lumican as a potential serum marker for acute aortic dissection using iTRAQ analysis. Liao et al. [4] revealed 26 differentially expressed proteins between aortic media of TAD patients and organ donors using conventional 2D-DIGE combined with MS to suggest that increased oxidative stress may play an important role in the disease.
In our study, aortic tissues were collected from patients in two age-and gender-matched groups, all of whom had a history of hypertension. Our study concentrated on the molecular changes of aortic tissue that lead to aortic dissection concomitant with high pressure. The studies outlined here suggest that aortic dissection is the end process of an array of different pathological processes that might begin with a tear in a damaged intima. Atherosclerotic ulcers could be an evolving stage in the development of such a tear [7] . Thus, in our research, the normal ascending aortic samples obtained in CABG served as a control group. Compared with organ donors as control subjects, molecular mechanisms related to atherosclerosis can thus be eliminated to the best of our ability.
In proteomics research, individual variation may interfere with the accuracy of the results. Zhang et al. [14] analysed normal liver samples using 2D-DIGE combined with matrix assisted laser desorption ionization/time of flight MS and found that when the sample size exceeded 7, the individual variations were not significant among the whole pool. Therefore, 13 tissue samples from each group were pooled to decrease the variation between the individual samples and reduce the overall number of samples to be tested.
In the present study, we analysed the identified 17 up-regulated and 19 down-regulated proteins using the MetaCore software. The results showed that the top three differentially occurring biological processes were cell-matrix adhesion interactions, proteolytic ECM remodelling and IL-6 signalling-related inflammation. These results suggest that ECM remodelling and inflammation through the above processes may contribute to the formation of TAD. Further experiments are required to test this hypothesis.
Recent evidence highlighting the dysregulation of TGF-β signalling in ascending TAAs has stimulated interest in this intracellular signalling pathway [1] . However, paradoxical discoveries about TGF-β signalling in the formation of TAAs have obfuscated the functional role of TGF-β. The role of TGF-β signalling in TADs remains to be explored.
Based on our study, fibrillin-1 was clearly down-regulated. Fibrillin-1 is a major structural component that contributes to the mechanical strength of the aortic wall and forms a lattice surrounding elastic fibres. Metabolically, fibrillin-1 has a crucial role in the regulation of the activity of growth factors and other microfibrillar proteins in the ECM, such as TGF-β1, because of its effect on the function of latent TGF-β-binding protein [15, 16] . Emilin-1 inhibits TGF-β1 signalling by binding to the TGF-β propeptide and preventing its maturation in the extracellular space [17] . Emilin-1 knockout mice present with hypertension (an effect attributed to an increase TGF-β1 activity) and show alterations in cell morphology and elastic fibres in the aortic wall [18] , but the role of emilin-1 in the pathogenesis of human TAAs remains to be defined. Our results demonstrate that emilin-1 was downregulated by approximately −2.333 times in TAD. Decorin appears to influence fibrillogenesis and also interacts with TGF-β. The work of Ferdous et al. [19] indicated that the inhibitory interaction between decorin and TGF-β1 significantly influenced the matrix organization and material behaviour of in vitro model tissues. Our results demonstrate that decorin was −6.486 times expressed in TADs. In conclusion, the result that the three important proteins interacting with TGF-β signalling were clearly differentially expressed suggests that TGF-β signalling may play a key role in the molecular mechanisms of TAD formation, as it does in TAA. The result that TGF-β itself was not differentially expressed in TADs reveals that more TGF-β is activated rather than newly expressed.
In our results, heat shock protein beta 1 (HSP27) is expressed 5.151 times higher in the TAD sample than in the control. HSP27 has been reported to participate in a wide variety of activities, and overexpression of HSP27 may lead to formation of aortic aneurysm [20] . Jia et al. [21] found that TGF-β1-induced transcript 1 protein (TGFB1/1) interacts with HSP27 to inhibit the activity of HSP27. Therefore, we hypothesized that HSP27 is highly expressed either to address the long-term high activation of TGF-β signalling or to serve as a downstream event when dissection occurs. Protein DJ-1 (PARK7) protects cells against oxidative stress and cell death. The result from our study that PARK7 is highly expressed in TAD may indicate that PARK7 protects vascular smooth muscle cells (VSMCs) from oxidation-induced dysfunction.
Tubulin and dynein are both structural components of VSMC. Dynein converts ATP energy into mechanical movement to transport cellular organelles for cell survival. This protein was clearly down-regulated in TAD (−58.076) and may be associated with dysfunction of VSMC. In our study, tubulin was 23.335 times up-regulated in TAD compared with the control. Tubulin is the protein that composes microtubules, which support the structure of VSMC and interact with focal adhesions to regulate the adhesion between VSMC and ECM. Thus, we hypothesize that the dysfunction of VSMCs through the abnormal expression of tubulin and dynein may be associated with the formation of TAD.
Other proteins identified in our study, such as serotransferrin, haemoglobin or fibrinogen, may be from residual blood clots in the TAD tissues.
Limitations of our study
First, the results of proteomics studies have to be validated using an alternative method, as we did using western blot technology. However, we did not validate all proteins discussed here. Secondly, the proteins and pathways identified by computerbased statistical algorithms need to be verified experimentally. It is unclear whether the differentially expressed proteins and the signalling pathways that we analysed are the definite cellular mechanisms of TAD. Thus, further work is necessary to confirm the results of our study. Our study might lead to new hypotheses and further research in the field of pathogenesis of TAD and might present evidence to help others design more effective strategies to improve the outcomes of this life-threatening disease.
